EASL clinical practice guidelines: management of hepatocellular carcinoma
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …
[PDF][PDF] Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta‐analysis
Multiphasic computed tomography (CT) and magnetic resonance imaging (MRI) are both
used for noninvasive diagnosis of hepatocellular carcinoma (HCC) in patients with cirrhosis …
used for noninvasive diagnosis of hepatocellular carcinoma (HCC) in patients with cirrhosis …
Motion artifact reduction using a convolutional neural network for dynamic contrast enhanced MR imaging of the liver
D Tamada, ML Kromrey, S Ichikawa… - Magnetic resonance in …, 2020 - jstage.jst.go.jp
Purpose: To improve the quality of images obtained via dynamic contrast enhanced MRI
(DCE-MRI), which contain motion artifacts and blurring using a deep learning approach …
(DCE-MRI), which contain motion artifacts and blurring using a deep learning approach …
Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis
S Lee, YY Kim, J Shin, WJ Son, YH Roh, JY Choi… - Radiology, 2023 - pubs.rsna.org
Background The Liver Imaging Reporting and Data System (LI-RADS) CT and MRI
algorithm applies equally to CT, MRI with extracellular contrast agents (ECA-MRI), and MRI …
algorithm applies equally to CT, MRI with extracellular contrast agents (ECA-MRI), and MRI …
LI-RADS version 2018 ancillary features at MRI
M Cerny, V Chernyak, D Olivié, JS Billiard… - Radiographics, 2018 - pubs.rsna.org
The Liver Imaging Reporting and Data System (LI-RADS) standardizes performance of liver
imaging in patients at risk for hepatocellular carcinoma (HCC) as well as interpretation and …
imaging in patients at risk for hepatocellular carcinoma (HCC) as well as interpretation and …
Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system …
TJ Fraum, R Tsai, E Rohe, DR Ludwig, A Salter… - Radiology, 2018 - pubs.rsna.org
Purpose To evaluate the diagnostic performance and interrater reliability of the Liver
Imaging Reporting and Data System (LI-RADS) version 2014 in differentiating …
Imaging Reporting and Data System (LI-RADS) version 2014 in differentiating …
A multicenter assessment of interreader reliability of LI-RADS version 2018 for MRI and CT
CW Hong, V Chernyak, JY Choi, S Lee, C Potu… - Radiology, 2023 - pubs.rsna.org
Background Various limitations have impacted research evaluating reader agreement for
Liver Imaging Reporting and Data System (LI-RADS). Purpose To assess reader agreement …
Liver Imaging Reporting and Data System (LI-RADS). Purpose To assess reader agreement …
[PDF][PDF] Doppler US and CT diagnosis of nutcracker syndrome
Objective To compare the diagnostic accuracy of dynamic computed tomography (CT) and
gadoxetate-enhanced magnetic resonance imaging (MRI) for characterization of hepatic …
gadoxetate-enhanced magnetic resonance imaging (MRI) for characterization of hepatic …
Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be …
Objectives To validate new diagnostic criteria for hepatocellular carcinoma (HCC) on
gadoxetic acid-enhanced MR imaging (Gd-EOB-MRI) using hypointensity on the …
gadoxetic acid-enhanced MR imaging (Gd-EOB-MRI) using hypointensity on the …
Gadoxetic acid–enhanced MRI of hepatocellular carcinoma: value of washout in transitional and hepatobiliary phases
Background Current Liver Imaging Reporting and Data System guidelines define the
washout appearance of gadoxetic acid–enhanced MRI only during the portal venous phase …
washout appearance of gadoxetic acid–enhanced MRI only during the portal venous phase …